Drug Challenge: Anticoagulants
Links shared publicly online about this topic.
- 498total visits
Drug Challenge: Anticoagulants
View full resource at nursingcenter.com
Tags: Drug, Anti-Clotting Medication, Anticoagulant, Coumadin, Bristol-Myers Squibb
Most Recently Shared on February 18, 2011 at 11:58 am By:
Drug Challenge: Anticoagulants http://bit.ly/i68uF8
Warfarin and aspirin compared as anticoagulants - Health News - NHS Choices
nhs.uk — “Taking aspirin to reduce blood-clotting is “as safe and just as effective as warfarin”, The Daily Telegraph has today reported. Both drugs have long been used to prevent potentially dangerous blood clots...” View full resource at nhs.uk
Most Recently Shared on May 4, 2012 at 12:55 am By:
Catherine Saxelby - Foodwatch Nutritionist and Dietitian
New from NHS: Aspirin vs warfarin: which is better? - Taking aspirin to reduce blood-clotting is “as safe and just a... http://t.co/08Di6ZsJ
As Diabetes Rises In Kids, So Do Treatment Challenges : Shots - Health Blog : NPR
npr.org — “A common pill to treat Type 2 diabetes showed disappointing results when used by adolescents. Adding another drug helped a little, but lifestyle changes didn't improve the kids' ability to control their blood sugar.” View full resource at npr.org
Most Recently Shared on April 30, 2012 at 8:27 pm By:
Dr Ted Portnay Doctor, Internist, Cardiologist, and Physician
As Diabetes Rises In Kids, So Do Treatment Challenges-More at http://t.co/afsC3HGM
Supreme Court: Generic drugmaker may sue over brand patent - amednews.com
ama-assn.org — “The ultimate outcome could be that such drug manufacturers can introduce their products sooner.” View full resource at ama-assn.org
Most Recently Shared on April 30, 2012 at 7:49 pm By:
AmericanMedicalNews Health Organization and Health News
Can generic drugmakers sue brand-name companies over the scope of their patents? http://t.co/Mq9qyJtR
FDA Tries to Disavow Role in Higher Hurdles for New Drugs - Forbes
forbes.com — “As evidenced by various posts that I have written over the past year (e.g. “Why Doesn’t the FDA Get more Respect?”), I appreciate both the important role that the FDA has in bringing new medicines to patients as well as the challenges it faces both politically and scientifically. Furthermore, I [...]” View full resource at forbes.com
Most Recently Shared on April 30, 2012 at 5:15 pm By:
blogaceutics Pharma and Health Communicator
FDA Tries to Disavow Role in Higher Hurdles for New Drugs - Forbes http://t.co/NO8egX1w
As Diabetes Rises In Kids, So Do Treatment Challenges : Shots - Health Blog : NPR
npr.org — “A common pill to treat Type 2 diabetes showed disappointing results when used by adolescents. Adding another drug helped a little, but lifestyle changes didn't improve the kids' ability to control their blood sugar.” View full resource at npr.org
Most Recently Shared on April 30, 2012 at 3:59 pm By:
As Diabetes Rises In Kids, So Do Treatment Challenges http://t.co/B0CpsHAR
U.S. anti-cocaine push embitters Peru chocolate makers | Reuters
reuters.com — “LIMA (Reuters) - Connoisseurs who take chocolate as seriously as sommeliers study wine are challenging the widespread use of an inferior cocoa pushed by the U.S. government in its war against drugs in” View full resource at reuters.com
Most Recently Shared on April 29, 2012 at 12:14 pm By:
Anthony, PhD Doctor, Psychologist, and PhD
U.S. anti-cocaine push embitters Peru chocolate makers http://t.co/hJLreLD4 #DrANews
Heart: Dabi cost-effective in U.K. analysis
cardiovascularbusiness.com — “Dabigatran, like other novel drugs, has upped the ante for the anticoagulant market due its ability to prevent stroke in atrial fibrillation (AF) patients without the need for continuous monitoring, like warfarin. However, while dabigatran has become a hit with some clinicians, many wonder whether the drug is cost-effective.” View full resource at cardiovascularbusiness.com
Most Recently Shared on April 24, 2012 at 4:15 pm By:
CardioBusiness Health Magazine
Dabigatran may be cost effective for U.K. population http://t.co/AT2hEWID #anticoagulants
Novartis challenges UK Avastin use in eye disease | Reuters
reuters.com — “ZURICH/LONDON (Reuters) - Swiss drugmaker Novartis is challenging the use of a cheap alternative to its eye drug Lucentis in parts of Britain, sparking a row over cost versus safety in treating a common” View full resource at reuters.com
Most Recently Shared on April 24, 2012 at 11:12 am By:
Novartis challenges UK Avastin use in eye disease: ZURICH/LONDON (Reuters) - Swiss drugmaker Novartis is challen... http://t.co/zisDalJq
Global, common approach to pharmaceutical supply chain integrity the focus of workshop
eurekalert.org — “The increasing globalization of the drug supply presents a host of public health challenges: theft and diversion of medicines, growth of illegal Internet pharmacies and insertion of adulterated medicines or ingredients into the supply chain. As pharmaceutical companies, regulatory authorities, lawmakers, healthcare practitioners and others continue to determine the best approaches to securing increasingly complex supply chains and protecting patients from potentially dangerous products, USP is c” View full resource at eurekalert.org
Most Recently Shared on April 17, 2012 at 6:51 pm By:
US Pharmacopeia Health Organization and Pharma
Global approach to Rx supply chain integrity focus of USP workshop, FDA's Bernstein to keynote. Early reg ends 4/20 http://t.co/Ugra9IKM
Frustrated ALS Patients Concoct Their Own Drug - WSJ.com
online.wsj.com — “Some patients with fatal Lou Gehrig's disease are trying to brew their own version of an experimental compound at home and testing it on themselves.” View full resource at online.wsj.com
Most Recently Shared on April 16, 2012 at 2:10 pm By:
Kent Bottles, MD Doctor, Pathologist, and Physician
Frustrated ALS Patients Concoct Their Own Drug http://t.co/zZWkjE6k via @WSJ
Nanostars Deliver Drug Directly to Cancer Cells
lurie.northwestern.edu — “Nanotechnology offers powerful new possibilities for targeted cancer therapies, but the design challenges are many. Northwestern University scientists now are the first to develop a simple but specialized nanoparticle that can deliver a drug directly to a cancer cell's nucleus -- an important feature for effective treatment.” View full resource at lurie.northwestern.edu
Most Recently Shared on April 11, 2012 at 7:57 pm By:
Dr. P. D Tapp Doctor, Health Executive, and PhD
Nrthwstrn-U scientists first to develop specialized nanoparticles to deliver drugs directly to cancer cell nuclei http://t.co/iD9Ef4B2
Investing in Biotech Isn’t Just for Investors Anymore | Xconomy
xconomy.com — “There hasn't been much to crow about for years in the world of biotech financing. There's no getting around the fact that new drugs still take a long time and a” View full resource at xconomy.com
Most Recently Shared on April 9, 2012 at 10:04 am By:
blogaceutics Pharma and Health Communicator
Investing in Biotech Isn’t Just for Investors Anymore | Xconomy http://t.co/s63agYqn
TONIX Pharmaceuticals Completes Pharmacokinetic Study on New Formulation of TNX-102 for Fibromyalgia - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Tonix Pharmaceuticals Holding Corp. , a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system completed a pharmacokinetic study of the first formulation of its lead drug, TNX-102, for the treatment of fibromyalgia syndrome .” View full resource at finance.yahoo.com
Most Recently Shared on April 6, 2012 at 2:01 am By:
TONIX Pharmaceuticals Completes Pharmacokinetic Study on New Formulation of TNX-102 for Fibromyalgia: Tonix Phar... http://t.co/pdPV40RY
Tiny hitchhikers attack cancer cells: Gold nanostars first to deliver drug directly to cancer cell nucleus
physorg.com — “Nanotechnology offers powerful new possibilities for targeted cancer therapies, but the design challenges are many. Northwestern University scientists now are the first to develop a simple but specialized nanoparticle that can deliver a drug directly to a cancer cell's nucleus -- an important feature ...” View full resource at physorg.com
Most Recently Shared on April 5, 2012 at 2:59 pm By:
Tiny hitchhikers attack cancer cells: Gold nanostars first to deliver drug directly to cancer cell nucleus http://t.co/uyfZap8P
ACP Internist, April 2012 - New drugs could improve anticoagulation rates
acpinternist.org — “ACP Internist, April 2012 - New drugs could improve anticoagulation rates” View full resource at acpinternist.org
Most Recently Shared on April 5, 2012 at 12:05 pm By:
New drugs could improve anticoagulation rates http://t.co/zred3vVz #ptsafey
Advertisement
